Cur-NIPAAM-MAA-NP’s reduced the expression of the heart failure indicators β-myosin heavy-chain gene, B-type natriuretic peptide, and atrial natriuretic peptide, thereby validating its cardioprotective efficacy (Daya et al., 2022). This evidence concerns the gene NPPA and heart failure.